This is not an official government website.
© 2026 PLEJ LC. All rights reserved.
Congressional Daily Record
This section is about changes proposed to a bill or resolution. It mentions committees such as Committee on Commerce, Science, and Transportation, members such as Marsha Blackburn.
Issued
June 24, 2026
senate side of the record
People
1
Linked members mentioned in this section
Legislation
0
No linked legislation in this section
Committees
3
Committees connected to this section
Senate Holds
0
No hold activity linked here
Source Document
Connected Data
Source Control
Reader mode is for comprehension. The linked government PDF is the official published source.
Download official Senate Record PDFReturn to issue contextSA 6098. Mrs. BLACKBURN submitted an amendment intended to be proposed by her to the bill S. 4784, to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; which was ordered to lie on the table; as follows:
At the appropriate place in title X, insert the following:
SEC. 10__. AUTHORITY OF NATIONAL DRUG CONTROL POLICY WITH
RESPECT TO THE WORLD ANTI-DOPING AGENCY.
Section 701 of the Office of National Drug Control Policy
Reauthorization Act of 2006 (21 U.S.C. 2001) is amended—
(1) by striking subsection (a) and inserting the following:
“(a) Definitions.—In this subchapter:
“(1) Amateur athlete.—The term `amateur athlete' has the
meaning given that term in section 220501(b)(1) of title 36,
United States Code.
“(2) Amateur athletic competition.—The term `amateur
athletic competition' has the meaning given that term in
section 220501(b)(2) of title 36, United States Code.
“(3) Independent athlete.—The term `independent athlete'
means a current or former amateur athlete who does not serve,
in any capacity—
“(A) on the International Olympic Committee;
“(B) on the International Paralympic Committee;
“(C) at an international sports federation recognized by
the International Olympic Committee or the International
Paralympic Committee;
“(D) on the United States Olympic and Paralympic
Committee;
“(E) at a national governing body (as defined in section
220501(b)(9) of title 36, United States Code); or
“(F) at the World Anti-Doping Agency.
“(4) United states olympic and paralympic committee.—The
term `United States Olympic and Paralympic Committee' means
the organization established by chapter 2205 of title 36,
United States Code.”;
(2) in subsection (b), by striking “United States Olympic
Committee” each place it appears and inserting “United
States Olympic and Paralympic Committee”; and
(3) by adding at the end the following:
“(d) Authority With Respect to the World Anti-Doping
Agency.—
“(1) Annual determination.—Not later than 180 days after
the date of the enactment of this subsection, and annually
thereafter, the Office of National Drug Control Policy, in
consultation with the United States Anti-Doping Agency, the
United States Olympic and Paralympic Committee, and the
Athletes' Advisory Council (established and maintained under
section 220504(b)(2)(A) of title 36, United States Code)
shall make a determination as to whether the World Anti-
Doping Agency—
“(A) has a credible and independent governance model that
provides for fair representation of the United States;
“(B) fully implements or has implemented governance
reforms to ensure independent governance; and
“(C) has fair processes and procedures to select
independent athletes, including athletes from the United
States and other democratic countries, or representatives of
such athletes, for decision-making roles on the Executive
Committee and the Foundation Board, and in all relevant
expert advisory groups, standing committees, permanent
special committees, and working groups of the World Anti-
Doping Agency.
“(2) Accountability.—In the case of a determination under
paragraph (1) that the World Anti-Doping Agency has not met
the criteria set forth in subparagraphs (A), (B), or (C) of
that paragraph, the Office of National Drug Control Policy,
in consultation with the United States Anti-Doping Agency,
the United States Olympic and Paralympic Committee, and the
Athletes' Advisory Council (established and maintained under
section 220504(b)(2)(A) of title 36, United States Code),
shall use all available tools and best efforts to bring the
World Anti-Doping Agency into compliance with the criteria
set forth in that paragraph.
“(3) Report.—In the case of a determination under
paragraph (1) that the World Anti-Doping Agency has not met
the criteria set forth in subparagraphs (A), (B), or (C) of
that paragraph, not later than 180 days after the date on
which that determination is made, the Office of National Drug
Control Policy, in consultation with the United States Anti-
Doping Agency, the United States Olympic and Paralympic
Committee, and the Athletes' Advisory Council (established
and maintained under section 220504(b)(2)(A) of title 36,
United States Code) shall submit to the appropriate
committees of Congress a report that describes the barriers
to participation and fair representation of the United States
on the Executive Committee, the Foundation Board, and all
relevant expert advisory groups, standing committees,
permanent special committees, and working groups of the World
Anti-Doping Agency.
“(4) Voluntary nonpayment of dues.—
“(A) In general.—In the case of a determination under
paragraph (1) that the World Anti-Doping Agency has not met
the criteria set forth in subparagraphs (A), (B), or (C) of
that paragraph, the Office of National Drug Control Policy,
in consultation with the appropriate committees of Congress,
may voluntarily withhold up to the full amount of any funds
made available for the payment of the United States
membership dues to the World Anti-Doping Agency.
“(B) Return of funds after noncompliance.—Unless
otherwise specified by law, any funds made available for the
payment of the United States membership dues to the World
Anti-Doping Agency that have been voluntarily withheld
pursuant to subparagraph (A) and have not been obligated
prior to the end of an applicable fiscal year shall be
returned to the general fund of the Treasury.
“(5) Spending plan.—Not later than 30 days before the
Office of National Drug Control Policy obligates funds to the
World Anti-Doping Agency, the Office of National Drug Control
Policy shall submit to the appropriate committees of Congress
a spending plan and explanation of proposed uses of such
funds.
“(6) Appropriate committees of congress defined.—In this
subsection, the term `appropriate committees of Congress'
means—
“(A) the Committee on Commerce, Science, and
Transportation of the Senate;
“(B) the Committee on Appropriations of the Senate;
“(C) the Committee on Energy and Commerce of the House of
Representatives; and
“(D) the Committee on Appropriations of the House of
Representatives.”.